BlackRock increased its holdings in WEIGAO GROUP (01066) by 2.7272 million shares at an average price of approximately HKD 3.38 per share.
On July 31, BlackRock increased its holdings in Weigao Group (01066) by 2.7272 million shares, at a price of HKD 3.3812 per share, for a total amount of approximately HKD 9.2212 million.
The latest information from the Hong Kong Stock Exchange shows that on July 31, BlackRock increased its stake in WEIGAO GROUP (01066) by 2.7272 million shares, at a price of HK$3.3812 per share, for a total amount of approximately HK$9.2212 million. After the increase, the latest number of shares held is approximately 229 million shares, with the latest shareholding ratio at 5.06%.
Related Articles
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
RECOMMEND
